Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Xu et al. Nucleosome Clustering as a Biomarker and Mechanistic Switch for Reprogramming Cells. <i>Cells</i> 2026, <i>15</i>, 113.

Cells·2026
Same author

A Fracture Healing Odyssey: Kinematic Comparison of Unions and Nonunions in Human Lower-Extremity Long Bones Treated with Intramedullary Nailing: A Retrospective Cohort Study.

The Journal of bone and joint surgery. American volume·2026
Same author

Replication protein A protects lagging strand gaps, restricting PARP inhibitor-induced synthetic lethality in BRCA1-deficient tumors.

Nucleic acids research·2026
Same author

Dynamic Self-Clickable Decellularized Matrix Hydrogels for Regulating Vascularity and Enhancing Muscle Regeneration.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Reframing RB Tumor Suppressor Dysfunction as a Therapeutic Vulnerability in Cancer.

Cancers·2026
Same author

Environmental concentration of chlorantraniliprole induces dysbiosis of gut microbiota and metabolism in crayfish (Procambarus clarkii).

Ecotoxicology and environmental safety·2026
Same journal

Non-canonical amino acid incorporation enables minimally disruptive labeling of stress granule and TDP-43 proteinopathy.

eLife·2026
Same journal

Analysis of dendritic input currents during place field dynamics.

eLife·2026
Same journal

TopoMetry systematically learns and evaluates the latent geometry of single-cell data.

eLife·2026
Same journal

Navigating the path: Advice to physician-scientists on choosing a clinical specialty.

eLife·2026
Same journal

Neural activity profiles reveal overlapping, intermingled subpopulations spanning area borders in mouse sensorimotor cortex.

eLife·2026
Same journal

The exquisite mechanics of a tsetse bite.

eLife·2026
See all related articles

Related Experiment Video

Updated: Aug 6, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K

Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins.

Kexin Li1,2, Qingji Huo1,2, Nathan H Dimmitt2

  • 1Department of Pharmacology, School of Pharmacy, Harbin Medical University, Harbin, China.

Elife
|March 21, 2023
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem cell-derived proteins show potential in treating osteosarcoma (OS) by inhibiting bone destruction. Activating specific pathways in stem cells enhanced their tumor-suppressing capabilities, offering a novel therapeutic avenue for this bone cancer.

Keywords:
CD47MSCPCOLCEcalreticulincancer biologymouseosteosarcomaproteome

More Related Videos

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.3K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.6K

Related Experiment Videos

Last Updated: Aug 6, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.3K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.6K

Area of Science:

  • Oncology
  • Biotechnology
  • Regenerative Medicine

Background:

  • Osteosarcoma (OS) is a primary bone cancer predominantly affecting children and young adults.
  • Standard chemotherapy for OS has limitations, necessitating novel therapeutic strategies.
  • Mesenchymal stem cells (MSCs) and their secreted proteins are being explored for cancer therapy.

Purpose of the Study:

  • To investigate the potential of MSCs-derived proteomes and OS-elevated proteins as a protein-based therapy for osteosarcoma.
  • To evaluate the tumor-suppressing ability of MSCs-conditioned medium (CM) and modified MSCs (iTSCs).
  • To explore the therapeutic efficacy of CM in inhibiting tumor-induced bone destruction in a mouse model.

Main Methods:

  • Collected conditioned medium (CM) from MSCs and activated MSCs (iTSCs) via PKA activation.
  • Administered CM directly and via hydrogel in a mouse model of OS.
  • Analyzed protein enrichment in CM, including calreticulin (CALR) and PCOLCE.
  • Examined interactions between identified proteins (e.g., CALR with CD47, PCOLCE with amyloid precursor protein) and their expression in OS tissues.

Main Results:

  • MSCs-derived CM inhibited tumor-induced bone destruction in a mouse model, with additive effects when combined with cisplatin.
  • Activation of PKA converted MSCs into induced tumor-suppressing cells (iTSCs).
  • Calreticulin (CALR) and PCOLCE were identified as extracellular tumor suppressors in CM, with elevated CALR transcripts in OS tissues.
  • PCOLCE interacted with amyloid precursor protein, a poor prognostic marker in OS.

Conclusions:

  • MSCs-derived proteins, particularly calreticulin and PCOLCE, demonstrate extracellular tumor-suppressing activity against osteosarcoma.
  • A paradoxical strategy utilizing OS transcriptomes for treatment, potentially through engineered MSCs, is supported by these findings.
  • This study highlights the potential of protein-based therapies derived from stem cells and leveraging tumor-specific proteins for osteosarcoma treatment.